Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
88,025,718
-
Share change
-
-3,853,009
-
Total reported value
-
$654,040,259
-
Put/Call ratio
-
44%
-
Price per share
-
$2.82
-
Number of holders
-
121
-
Value change
-
-$12,561,473
-
Number of buys
-
41
-
Number of sells
-
85
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q1 2020
As of 31 Mar 2020,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
88,025,718 shares.
The largest 10 holders included
BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, BRANDES INVESTMENT PARTNERS, LP, VANGUARD GROUP INC, Silver Point Capital L.P., NORTHERN TRUST CORP, Connor, Clark & Lunn Investment Management Ltd., CITADEL ADVISORS LLC, and STATE STREET CORP.
This page lists
121
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.